Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
European Urology Focus|December 16, 2018
Health Technology Assessment and Health Care Utilisation in the Management of Early Prostate CancerRichard De Abreu Lourenco, Scott Williams
Pharmacoeconomics|January 22, 2015
Pharmacological management of chronic lower back pain: a review of cost effectivenessMarion Haas, Richard De Abreu Lourenco
International Journal of Technology Assessment in Health Care|July 8, 2025
Stakeholder survey about broad elements of value in health technology assessment in Australia: industry and academia more similar than differentMaria Farris, Stephen Goodall, Richard De Abreu Lourenco
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 1, 2024
Discrete Event Simulation to Incorporate Infusion Wait-Time When Assessing Cost-Effectiveness of a Chimeric-Antigen Receptor T Cell TherapyAmy Gye, Richard De Abreu Lourenco, Stephen Goodall
Pharmacoeconomics|October 20, 2022
Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment ArrangementAmy Gye, Stephen Goodall, Richard De Abreu Lourenco
International Journal of Technology Assessment in Health Care|June 14, 2023
A systematic review of economic evaluations for <i>RPE65</i>-mediated inherited retinal disease including HTA assessment of broader valueMaria Farris, Stephen Goodall, Richard De Abreu Lourenco
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
A Systematic Review of Health Technology Assessments of Chimeric Antigen Receptor T-Cell Therapies in Young Compared With Older PatientsAmy Gye, Stephen Goodall, Richard De Abreu Lourenco
Pharmacoeconomics|September 7, 2024
Different Models, Same Results: Considerations When Choosing Between Approaches to Model Cost Effectiveness of Chimeric-Antigen Receptor T-Cell Therapy Versus Standard of CareAmy Gye, Richard De Abreu Lourenco, Stephen Goodall
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 28, 2008
Audit of endometrial biopsy at outpatient hysteroscopySimon Ghaly, Richard de Abreu Lourenco, Jason A Abbott
Public Health|November 12, 2024
Sugar-sweetened beverage consumption in Thailand: Determinants and variation across socioeconomic statusKittiphong Thiboonboon, Richard De Abreu Lourenco, Jody Church, et al.
Pageof 10